Global Medical REIT Inc. (GMRE) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Current Price
$35.74
Price Target
$40.00
Target Range
$40.00 — $40.00
Analyst Rating
Buy
Forward P/E595.7x
Trailing P/E115.3x
Forward PEG—
Implied Growth-67.9%
Median Target$40.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$40
+11.9%
Consensus
$40
+11.9%
Bull Case
$40
+11.9%
Valuation Model TargetsConfidence: 19/100
Bear$-83
Base$35
Bull$446
GMRE Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Global Medical REIT Inc. (GMRE) has a Wall Street consensus price target of $40.00, based on estimates from 22 covering analysts. With the stock currently trading at $35.74, this represents a potential upside of +11.9%. The company has a market capitalization of $94M.
Analyst price targets range from a low of $40.00 to a high of $40.00, representing a 0% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, GMRE trades at a trailing P/E of 115.3x and forward P/E of 595.7x. Analysts expect EPS to grow -67.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $34.63, with bear and bull scenarios of $-82.84 and $445.79 respectively. Model confidence stands at 19/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Real Estate stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside-2.3%
Avg Forward P/E41.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CHCTCommunity Healthcare Trust Incorporated | $505M | $17.68 | $18.50 | +4.6% | Hold | 37.6x | 16 |
 NXRTNexPoint Residential Trust, Inc. | $756M | $29.80 | $27.00 | -9.4% | Hold | — | 10 |
 PLYMPlymouth Industrial REIT, Inc. | $979M | $21.98 | $21.00 | -4.5% | Hold | — | 16 |
 HRHealthcare Realty Trust Incorporated | $7.0B | $20.00 | $19.33 | -3.3% | Hold | — | 29 |
 DOCHealthpeak Properties, Inc. | $13.7B | $19.66 | $17.86 | -9.2% | Buy | 100.9x | 40 |
 MPWMedical Properties Trust, Inc. | $3.4B | $5.65 | $5.00 | -11.5% | Hold | 49.4x | 28 |
 OHIOmega Healthcare Investors, Inc. | $13.7B | $46.13 | $49.14 | +6.5% | Hold | 23.4x | 28 |
 SBRASabra Health Care REIT, Inc. | $5.2B | $20.58 | $21.20 | +3.0% | Hold | 29.8x | 29 |
 LTCLTC Properties, Inc. | $1.9B | $38.64 | $36.00 | -6.8% | Hold | 19.9x | 22 |
 CTRECareTrust REIT, Inc. | $8.8B | $39.51 | $42.50 | +7.6% | Buy | 26.6x | 19 |
Upside Potential Comparison
CTREOHICHCTSBRAHRPLYMLTCDOCSee GMRE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GMRE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GMRE vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonGMRE — Frequently Asked Questions
Quick answers to the most common questions about buying GMRE stock.
What is the GMRE stock price target for 2026?
Global Medical REIT Inc. (GMRE) has a consensus 12-month price target of $40, implying 11.9% upside from $35.74. The 22 analysts covering GMRE see moderate appreciation potential.
Is GMRE a buy, sell, or hold?
GMRE has a consensus rating of "Buy" based on 22 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $40 implies 11.9% upside from current levels.
Is GMRE stock overvalued or undervalued?
At a forward P/E of 595.6667x, GMRE trades at a premium valuation. The consensus price target of $40 (11.9% upside) suggests analysts still see growth justifying the multiple.
How high can GMRE stock go?
The most bullish Wall Street analyst has a price target of $40 for GMRE, while the most conservative target is $40. The consensus of $40 represents the median expectation. Our quantitative valuation model projects a bull case target of $446 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover GMRE stock?
GMRE is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 9 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the GMRE stock forecast?
The 12-month GMRE stock forecast based on 22 Wall Street analysts shows a consensus price target of $40, with estimates ranging from $40 (bear case) to $40 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $35, with bear/bull scenarios of $-83/$446.
What is GMRE's fair value based on fundamentals?
Our quantitative valuation model calculates GMRE's fair value at $35 (base case), with a bear case of $-83 and bull case of $446. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 19/100.
What is GMRE's forward P/E ratio?
GMRE trades at a forward P/E ratio of 595.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 115.3x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy GMRE stock?
Wall Street analysts are optimistic on GMRE, with a "Buy" consensus rating and $40 price target (11.9% upside). 13 of 22 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do GMRE price targets vary so much?
GMRE analyst price targets range from $40 to $40, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40 consensus represents the middle ground. Our model's $-83-$446 range provides an independent fundamental perspective.